BEIJING – China’s basic medical insurance program supports more than 1.3 billion people. Still, the system shows clear signs of stress. Official updates describe 2025 as “stable,” with about 2.95 trillion yuan in revenue and 2.42 trillion yuan in spending.
However, several pressure points tell a different story. In key places, costs rise faster than income because the population is aging, care gets more expensive, and policy changes have narrowed access to some effective treatments.
Local accounts show how fast the gap is growing. In 2024, resident medical insurance funds posted large deficits in major cities. Beijing reported a shortfall of 525.6 million yuan. Tianjin recorded more than 1.3 billion yuan. Those numbers point to a budget strain that can push more costs onto regular families.
To cover these shortfalls, officials have leaned on a surprising source, welfare lottery funds. These funds usually support social programs such as elder services and disability aid. Now, larger shares go toward medical insurance gaps. In some cases, reports suggest the share has roughly doubled to around 20%. Even so, national totals remain hard to confirm, since broader fiscal reporting remains limited.
The Main Drivers, Aging and Policy Choices Put the Fund Under Pressure
Demographics sit at the center of the problem. China’s older population continues to grow quickly. By 2040, adults 65 and older are projected to make up 27% of the population. As a result, demand rises for long-term care, chronic disease treatment, and more hospital use.
At the same time, healthcare spending has jumped over the past 20 years. Reports describe nearly a 20-fold increase, reaching trillions of yuan each year. That growth makes it harder for insurance funds to keep up, especially at the local level.
Policy choices add another layer. The state has pushed cost controls through volume-based purchasing and broader use of domestic generics. These steps can lower prices, but they also reduce access to many foreign-branded new drugs through reimbursement list changes.
Some doctors and critics say certain generics don’t work as well for every patient. When treatment takes longer, patients can face more visits and more complications. Over time, that can raise total costs instead of lowering them. Public frustration has flared at times, which reflects a wider concern that price targets can come at the expense of results.
- An aging population increases chronic illness, including heart disease, cancer, and neurological disorders.
- Changes to drug coverage reduce access to some advanced therapies.
- Longer treatment cycles can raise per-patient costs and strain city budgets.
Because of these forces, some local funds have moved from occasional swings to ongoing deficits.
Lottery Money, From Social Welfare Support to a Healthcare Backstop
China’s welfare lottery system includes sports and charity lotteries. In 2025, lottery sales reached nearly 628 billion yuan (about $90 billion). That marked only a 0.7% rise from the year before, which suggests slower growth during a tougher economy. While proceeds still support traditional welfare uses, more money now patches medical insurance budgets.
Several trends stand out:
- In some targeted uses, diversion levels appear to reach about 20% or more.
- The shift offers quick relief, but it doesn’t last forever.
- When the economy slows, ticket sales can weaken, which shrinks the pool.
Lottery funds have long played a large role in elder-related programs. Reports often place that share around 60% in certain welfare efforts. However, heavier reliance on lottery funding for healthcare creates new risks. If households cut back on non-essential spending, lottery revenue can fall, and the backup plan gets smaller.
Unequal Access and Corruption, More Strain on a System Already Under Load
As resources tighten, unequal access becomes harder to ignore. Premium care often flows to “cadre wards,” specialized hospital areas that serve top officials and other elites. These wards tend to offer better equipment, shorter waits, and higher service levels.
Meanwhile, many ordinary patients deal with long lines, higher out-of-pocket bills, and fewer options for advanced care. This gap fuels public resentment because people see public money supporting two standards of treatment.
Corruption remains another drain, even with enforcement campaigns. Authorities have punished large numbers of people in healthcare fraud cases. Some cases involved hospital leaders who created fake treatments or inflated billing to extract insurance payouts.
In a major sweep, more than 350 prominent figures faced discipline. Bribery, kickbacks, and favoritism continue to damage trust, especially when citizens feel they pay more but receive less.
- Cadre wards concentrate premium services for elites.
- Fraud and inflated claims pull money away from patient care.
- Regular households face higher premiums, lower reimbursements, and rising worry about coverage stability.
A Patchwork Plan That Can’t Hold Forever
Beijing’s move to redirect more lottery welfare funds may steady budgets in the short term. Still, it doesn’t fix the core issues. An aging society needs a stronger funding base, fairer access to care, and tighter control over fraud. It also needs drug policies that balance price with results, so patients don’t pay later for cheaper choices today.
Without deeper reforms, deficits could spread to more regions. Enrollment could keep dropping, since millions have exited resident programs in recent years. As confidence falls, people may stop seeing medical insurance as reliable protection. Over time, the safety net could weaken, and inequality could grow.
Economic pressure adds another limit. When the public buys fewer lottery tickets, less money remains to cover gaps. That leaves the system leaning on a shrinking support beam, while costs continue to rise.
Related News:
China’s Deadly Tech and Infrastructure Shortcuts Cause Disaster
